ID   MTNB_HUMAN              Reviewed;         242 AA.
AC   Q96GX9; A8K9D3; Q6PJX6; Q8WVU2; Q96HK2; Q9Y318;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   18-JUN-2025, entry version 179.
DE   RecName: Full=Methylthioribulose-1-phosphate dehydratase {ECO:0000255|HAMAP-Rule:MF_03116};
DE            Short=MTRu-1-P dehydratase {ECO:0000255|HAMAP-Rule:MF_03116};
DE            EC=4.2.1.109 {ECO:0000255|HAMAP-Rule:MF_03116, ECO:0000269|PubMed:24367089};
DE   AltName: Full=APAF1-interacting protein {ECO:0000255|HAMAP-Rule:MF_03116};
DE            Short=hAPIP;
GN   Name=APIP {ECO:0000255|HAMAP-Rule:MF_03116}; ORFNames=CGI-29;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS TRP-7 AND
RP   TYR-76.
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS TRP-7;
RP   ARG-23; TYR-76 AND VAL-181.
RC   TISSUE=Bone marrow, Colon, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH APAF1, TISSUE SPECIFICITY, SUBCELLULAR LOCATION,
RP   AND ALTERNATIVE SPLICING (ISOFORM 2).
RX   PubMed=15262985; DOI=10.1074/jbc.m405747200;
RA   Cho D.-H., Hong Y.-M., Lee H.-J., Woo H.-N., Pyo J.-O., Mak T.W.,
RA   Jung Y.-K.;
RT   "Induced inhibition of ischemic/hypoxic injury by APIP, a novel Apaf-1-
RT   interacting protein.";
RL   J. Biol. Chem. 279:39942-39950(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   FUNCTION, PATHWAY, ALTERNATIVE SPLICING (ISOFORM 2), SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND MUTAGENESIS OF SER-84; SER-87; SER-89; HIS-115;
RP   HIS-117 AND HIS-195.
RX   PubMed=23285211; DOI=10.1371/journal.pone.0052877;
RA   Mary C., Duek P., Salleron L., Tienz P., Bumann D., Bairoch A., Lane L.;
RT   "Functional identification of APIP as human mtnB, a key enzyme in the
RT   methionine salvage pathway.";
RL   PLoS ONE 7:E52877-E52877(2012).
RN   [9]
RP   FUNCTION, INTERACTION WITH CASP1, AND MUTAGENESIS OF CYS-97 AND HIS-115.
RX   PubMed=22837397; DOI=10.1073/pnas.1206701109;
RA   Ko D.C., Gamazon E.R., Shukla K.P., Pfuetzner R.A., Whittington D.,
RA   Holden T.D., Brittnacher M.J., Fong C., Radey M., Ogohara C., Stark A.L.,
RA   Akey J.M., Dolan M.E., Wurfel M.M., Miller S.I.;
RT   "Functional genetic screen of human diversity reveals that a methionine
RT   salvage enzyme regulates inflammatory cell death.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:E2343-E2352(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 20-242 IN COMPLEX WITH ZINC,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, FUNCTION,
RP   PATHWAY, ACTIVE SITE, SUBUNIT, AND MUTAGENESIS OF GLN-96; CYS-97; HIS-115
RP   AND GLU-139.
RX   PubMed=24367089; DOI=10.1073/pnas.1308768111;
RA   Kang W., Hong S.H., Lee H.M., Kim N.Y., Lim Y.C., Le le T.M., Lim B.,
RA   Kim H.C., Kim T.Y., Ashida H., Yokota A., Hah S.S., Chun K.H., Jung Y.K.,
RA   Yang J.K.;
RT   "Structural and biochemical basis for the inhibition of cell death by APIP,
RT   a methionine salvage enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:E54-E61(2014).
CC   -!- FUNCTION: Catalyzes the dehydration of methylthioribulose-1-phosphate
CC       (MTRu-1-P) into 2,3-diketo-5-methylthiopentyl-1-phosphate (DK-MTP-1-P).
CC       Functions in the methionine salvage pathway, which plays a key role in
CC       cancer, apoptosis, microbial proliferation and inflammation. May
CC       inhibit the CASP1-related inflammatory response (pyroptosis), the
CC       CASP9-dependent apoptotic pathway and the cytochrome c-dependent and
CC       APAF1-mediated cell death. {ECO:0000255|HAMAP-Rule:MF_03116,
CC       ECO:0000269|PubMed:15262985, ECO:0000269|PubMed:22837397,
CC       ECO:0000269|PubMed:23285211, ECO:0000269|PubMed:24367089}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5-(methylsulfanyl)-D-ribulose 1-phosphate = 5-methylsulfanyl-
CC         2,3-dioxopentyl phosphate + H2O; Xref=Rhea:RHEA:15549,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:58548, ChEBI:CHEBI:58828;
CC         EC=4.2.1.109; Evidence={ECO:0000255|HAMAP-Rule:MF_03116,
CC         ECO:0000269|PubMed:24367089};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_03116, ECO:0000269|PubMed:24367089};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000255|HAMAP-Rule:MF_03116,
CC       ECO:0000269|PubMed:24367089};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=9.3 uM for S-methyl-5-thio-D-ribulose 1-phosphate;
CC         Vmax=1.39 umol/min/mg enzyme;
CC   -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via salvage
CC       pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate:
CC       step 2/6. {ECO:0000255|HAMAP-Rule:MF_03116,
CC       ECO:0000269|PubMed:23285211, ECO:0000269|PubMed:24367089}.
CC   -!- SUBUNIT: Homotetramer (PubMed:24367089). Interacts with APAF1
CC       (PubMed:15262985). May interact with CASP1 (PubMed:22837397).
CC       {ECO:0000255|HAMAP-Rule:MF_03116, ECO:0000269|PubMed:15262985,
CC       ECO:0000269|PubMed:22837397, ECO:0000269|PubMed:24367089}.
CC   -!- INTERACTION:
CC       Q96GX9; Q96GX9: APIP; NbExp=12; IntAct=EBI-359248, EBI-359248;
CC       Q96GX9; Q9UIF8: BAZ2B; NbExp=3; IntAct=EBI-359248, EBI-741542;
CC       Q96GX9; Q8IYR0: CFAP206; NbExp=3; IntAct=EBI-359248, EBI-749051;
CC       Q96GX9; Q9H8Y8: GORASP2; NbExp=3; IntAct=EBI-359248, EBI-739467;
CC       Q96GX9; P12268: IMPDH2; NbExp=3; IntAct=EBI-359248, EBI-353389;
CC       Q96GX9; Q8TBB1: LNX1; NbExp=11; IntAct=EBI-359248, EBI-739832;
CC       Q96GX9; Q96HA8: NTAQ1; NbExp=5; IntAct=EBI-359248, EBI-741158;
CC       Q96GX9; Q6ZVK8: NUDT18; NbExp=4; IntAct=EBI-359248, EBI-740486;
CC       Q96GX9; Q17RL8: PDZD4; NbExp=4; IntAct=EBI-359248, EBI-10239064;
CC       Q96GX9; P25786: PSMA1; NbExp=3; IntAct=EBI-359248, EBI-359352;
CC       Q96GX9; O00560: SDCBP; NbExp=5; IntAct=EBI-359248, EBI-727004;
CC       Q96GX9; P63208: SKP1; NbExp=3; IntAct=EBI-359248, EBI-307486;
CC       Q96GX9; Q16637: SMN2; NbExp=3; IntAct=EBI-359248, EBI-395421;
CC       Q96GX9; O14787: TNPO2; NbExp=4; IntAct=EBI-359248, EBI-431907;
CC       Q96GX9; Q9Y3Q8: TSC22D4; NbExp=4; IntAct=EBI-359248, EBI-739485;
CC       Q96GX9; P24278: ZBTB25; NbExp=3; IntAct=EBI-359248, EBI-739899;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03116,
CC       ECO:0000269|PubMed:15262985, ECO:0000269|PubMed:23285211}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Long;
CC         IsoId=Q96GX9-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=Q96GX9-3; Sequence=VSP_044403;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is ubiquitously expressed. Isoform 2 is
CC       expressed at lower levels and detected in heart, brain, pancreas,
CC       liver, placenta, skeletal muscle and kidney.
CC       {ECO:0000269|PubMed:15262985, ECO:0000269|PubMed:23285211}.
CC   -!- SIMILARITY: Belongs to the aldolase class II family. MtnB subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03116}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF132963; AAD27738.1; -; mRNA.
DR   EMBL; AK292648; BAF85337.1; -; mRNA.
DR   EMBL; AC107928; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008440; AAH08440.1; -; mRNA.
DR   EMBL; BC009077; AAH09077.1; -; mRNA.
DR   EMBL; BC017594; AAH17594.1; -; mRNA.
DR   CCDS; CCDS7895.1; -. [Q96GX9-1]
DR   RefSeq; NP_057041.2; NM_015957.4. [Q96GX9-1]
DR   PDB; 4M6R; X-ray; 2.00 A; A/B/C/D=20-242.
DR   PDBsum; 4M6R; -.
DR   AlphaFoldDB; Q96GX9; -.
DR   SMR; Q96GX9; -.
DR   BioGRID; 119265; 53.
DR   FunCoup; Q96GX9; 1334.
DR   IntAct; Q96GX9; 53.
DR   STRING; 9606.ENSP00000379133; -.
DR   GlyGen; Q96GX9; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q96GX9; -.
DR   PhosphoSitePlus; Q96GX9; -.
DR   BioMuta; APIP; -.
DR   DMDM; 74731866; -.
DR   jPOST; Q96GX9; -.
DR   MassIVE; Q96GX9; -.
DR   PaxDb; 9606-ENSP00000379133; -.
DR   PeptideAtlas; Q96GX9; -.
DR   ProteomicsDB; 76681; -. [Q96GX9-1]
DR   Pumba; Q96GX9; -.
DR   Antibodypedia; 25889; 327 antibodies from 31 providers.
DR   DNASU; 51074; -.
DR   Ensembl; ENST00000395787.4; ENSP00000379133.3; ENSG00000149089.13. [Q96GX9-1]
DR   GeneID; 51074; -.
DR   KEGG; hsa:51074; -.
DR   MANE-Select; ENST00000395787.4; ENSP00000379133.3; NM_015957.4; NP_057041.2.
DR   UCSC; uc001mvs.4; human. [Q96GX9-1]
DR   AGR; HGNC:17581; -.
DR   CTD; 51074; -.
DR   DisGeNET; 51074; -.
DR   GeneCards; APIP; -.
DR   HGNC; HGNC:17581; APIP.
DR   HPA; ENSG00000149089; Low tissue specificity.
DR   MIM; 612491; gene.
DR   OpenTargets; ENSG00000149089; -.
DR   VEuPathDB; HostDB:ENSG00000149089; -.
DR   eggNOG; KOG2631; Eukaryota.
DR   GeneTree; ENSGT00390000001680; -.
DR   HOGENOM; CLU_006033_4_0_1; -.
DR   InParanoid; Q96GX9; -.
DR   OMA; WFPGTSG; -.
DR   OrthoDB; 191080at2759; -.
DR   PAN-GO; Q96GX9; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q96GX9; -.
DR   BRENDA; 4.2.1.109; 2681.
DR   PathwayCommons; Q96GX9; -.
DR   Reactome; R-HSA-111458; Formation of apoptosome.
DR   Reactome; R-HSA-1237112; Methionine salvage pathway.
DR   Reactome; R-HSA-9627069; Regulation of the apoptosome activity.
DR   SignaLink; Q96GX9; -.
DR   SIGNOR; Q96GX9; -.
DR   UniPathway; UPA00904; UER00875.
DR   BioGRID-ORCS; 51074; 66 hits in 1123 CRISPR screens.
DR   ChiTaRS; APIP; human.
DR   EvolutionaryTrace; Q96GX9; -.
DR   GeneWiki; APIP; -.
DR   GenomeRNAi; 51074; -.
DR   Pharos; Q96GX9; Tbio.
DR   PRO; PR:Q96GX9; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q96GX9; protein.
DR   Bgee; ENSG00000149089; Expressed in C1 segment of cervical spinal cord and 102 other cell types or tissues.
DR   ExpressionAtlas; Q96GX9; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046570; F:methylthioribulose 1-phosphate dehydratase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0019509; P:L-methionine salvage from methylthioadenosine; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0070269; P:pyroptotic inflammatory response; IMP:UniProtKB.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   FunFam; 3.40.225.10:FF:000003; Methylthioribulose-1-phosphate dehydratase; 1.
DR   Gene3D; 3.40.225.10; Class II aldolase/adducin N-terminal domain; 1.
DR   HAMAP; MF_03116; Salvage_MtnB_euk; 1.
DR   InterPro; IPR001303; Aldolase_II/adducin_N.
DR   InterPro; IPR036409; Aldolase_II/adducin_N_sf.
DR   InterPro; IPR017714; MethylthioRu-1-P_deHdtase_MtnB.
DR   InterPro; IPR027514; Salvage_MtnB_euk.
DR   NCBIfam; TIGR03328; salvage_mtnB; 1.
DR   PANTHER; PTHR10640; METHYLTHIORIBULOSE-1-PHOSPHATE DEHYDRATASE; 1.
DR   PANTHER; PTHR10640:SF7; METHYLTHIORIBULOSE-1-PHOSPHATE DEHYDRATASE; 1.
DR   Pfam; PF00596; Aldolase_II; 1.
DR   SMART; SM01007; Aldolase_II; 1.
DR   SUPFAM; SSF53639; AraD/HMP-PK domain-like; 1.
DR   neXtProt; NX_Q96GX9; -.
DR   PharmGKB; PA142672601; -.
DR   TreeFam; TF105632; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amino-acid biosynthesis; Apoptosis;
KW   Cytoplasm; Lyase; Metal-binding; Methionine biosynthesis; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Zinc.
FT   CHAIN           1..242
FT                   /note="Methylthioribulose-1-phosphate dehydratase"
FT                   /id="PRO_0000239022"
FT   ACT_SITE        139
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03116,
FT                   ECO:0000269|PubMed:24367089"
FT   BINDING         97
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03116,
FT                   ECO:0000305|PubMed:24367089"
FT   BINDING         115
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03116,
FT                   ECO:0000305|PubMed:24367089, ECO:0007744|PDB:4M6R"
FT   BINDING         117
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03116,
FT                   ECO:0000305|PubMed:24367089, ECO:0007744|PDB:4M6R"
FT   BINDING         195
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03116,
FT                   ECO:0000305|PubMed:24367089, ECO:0007744|PDB:4M6R"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..53
FT                   /note="MSGCDAREGDCCSRRCGAQDKEHPRYLIPELCKQFYHLGWVTGTGGGISLKH
FT                   G -> MLGRETVVPGDAARS (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_044403"
FT   VARIANT         7
FT                   /note="R -> W (in dbSNP:rs2956114)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_026575"
FT   VARIANT         23
FT                   /note="H -> R (in dbSNP:rs17850326)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_026576"
FT   VARIANT         76
FT                   /note="C -> Y (in dbSNP:rs1977420)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_026577"
FT   VARIANT         181
FT                   /note="M -> V (in dbSNP:rs17850327)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_026578"
FT   MUTAGEN         84
FT                   /note="S->A,D: Does not affect ability of cells to grow in
FT                   media where methionine is replaced by
FT                   5-methylthioadenosine; when associated with A,D-87 and
FT                   A,D-89."
FT                   /evidence="ECO:0000269|PubMed:23285211"
FT   MUTAGEN         87
FT                   /note="S->A,D: Does not affect ability of cells to grow in
FT                   media where methionine is replaced by
FT                   5-methylthioadenosine; when associated with A,D-84 and
FT                   A,D-89."
FT                   /evidence="ECO:0000269|PubMed:23285211"
FT   MUTAGEN         89
FT                   /note="S->A,D: Does not affect ability of cells to grow in
FT                   media where methionine is replaced by
FT                   5-methylthioadenosine; when associated with A,D-84 and
FT                   A,D-87."
FT                   /evidence="ECO:0000269|PubMed:23285211"
FT   MUTAGEN         96
FT                   /note="Q->A: Mildly reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:24367089"
FT   MUTAGEN         97
FT                   /note="C->A: Acts as a dominant negative mutant; unable to
FT                   use 5'-methylthioadenosine as source of methionine. Does
FT                   not affect the ability to bind CASP1 and to inhibit cell
FT                   death induced by CASP9 overexpression."
FT                   /evidence="ECO:0000269|PubMed:22837397"
FT   MUTAGEN         97
FT                   /note="C->A: Almost complete loss of enzyme activity.
FT                   Abolishes protection against pyroptosis. No effect on
FT                   anti-apoptotic activity."
FT                   /evidence="ECO:0000269|PubMed:24367089"
FT   MUTAGEN         115
FT                   /note="H->A: Almost complete loss of enzyme activity.
FT                   Abolishes protection against pyroptosis. No effect on
FT                   anti-apoptotic activity."
FT                   /evidence="ECO:0000269|PubMed:24367089"
FT   MUTAGEN         115
FT                   /note="H->A: Impaired ability of cells to grow in media
FT                   where methionine is replaced by 5-methylthioadenosine; when
FT                   associated with A-117 and A-195. Unable to inhibit both
FT                   CASP1 and CASP9 mediated cell death."
FT                   /evidence="ECO:0000269|PubMed:22837397,
FT                   ECO:0000269|PubMed:23285211"
FT   MUTAGEN         117
FT                   /note="H->A: Impaired ability of cells to grow in media
FT                   where methionine is replaced by 5-methylthioadenosine; when
FT                   associated with A-115 and A-195."
FT                   /evidence="ECO:0000269|PubMed:23285211"
FT   MUTAGEN         139
FT                   /note="E->A: Almost complete loss of enzyme activity.
FT                   Abolishes protection against pyroptosis. No effect on
FT                   anti-apoptotic activity."
FT                   /evidence="ECO:0000269|PubMed:24367089"
FT   MUTAGEN         195
FT                   /note="H->A: Impaired ability of cells to grow in media
FT                   where methionine is replaced by 5-methylthioadenosine; when
FT                   associated with 87-A--A-89."
FT                   /evidence="ECO:0000269|PubMed:23285211"
FT   CONFLICT        7
FT                   /note="R -> G (in Ref. 1; AAD27738)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        172
FT                   /note="D -> T (in Ref. 1; AAD27738)"
FT                   /evidence="ECO:0000305"
FT   HELIX           24..37
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   HELIX           42..44
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   STRAND          47..52
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   STRAND          55..58
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   HELIX           65..67
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   HELIX           70..72
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   STRAND          74..76
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   STRAND          82..84
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   HELIX           88..90
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   HELIX           98..108
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   STRAND          111..116
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   HELIX           119..127
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   STRAND          130..137
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   HELIX           139..143
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   TURN            147..149
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   STRAND          157..164
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   HELIX           170..183
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   STRAND          188..192
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   TURN            193..195
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   STRAND          196..203
FT                   /evidence="ECO:0007829|PDB:4M6R"
FT   HELIX           204..226
FT                   /evidence="ECO:0007829|PDB:4M6R"
SQ   SEQUENCE   242 AA;  27125 MW;  9B8D5D1435D6775A CRC64;
     MSGCDAREGD CCSRRCGAQD KEHPRYLIPE LCKQFYHLGW VTGTGGGISL KHGDEIYIAP
     SGVQKERIQP EDMFVCDINE KDISGPSPSK KLKKSQCTPL FMNAYTMRGA GAVIHTHSKA
     AVMATLLFPG REFKITHQEM IKGIKKCTSG GYYRYDDMLV VPIIENTPEE KDLKDRMAHA
     MNEYPDSCAV LVRRHGVYVW GETWEKAKTM CECYDYLFDI AVSMKKVGLD PSQLPVGENG
     IV
//
